Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Bactericidal Activity of Zabofloxacin vs Levofloxacin
NCT02212795Phase 1Completed
- Sponsor
- Dongwha Pharmaceutical Co., Ltd.
- Start
- May 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of zabofloxacin in bacterial infection (3 arms), sponsored by Dongwha Pharmaceutical Co., Ltd. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started May 2014; status: completed.
02
Drugs
zabofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02212795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212795.